Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system

2009131 citationsJournal Articlebronze Open Access

Authors

Jean‐Pierre Riveline · Centre Hospitalier Sud Francilien

J. Teynié · Centre Hospitalier Universitaire de Poitiers

S. Belmouaz · Université de Poitiers

Sylvia Franc

Dured Dardari · Centre Hospitalier Sud Francilien

Marc Bauwens · Université de Poitiers

Valérie Caudwell · Centre Hospitalier Sud Francilien

Abstract

CGM is a validated marker of glycaemic control in HD diabetic patients. This tool showed that A1c and fructosamine, despite being good markers of glycaemic control in non-HD diabetic patients, are of poor value in HD diabetic patients.

Topics & Keywords

Diabetes Management and Research Dialysis and Renal Disease Management Diabetes Treatment and Management

Publication Details

Published in: Nephrology Dialysis Transplantation

Volume 24, Issue 9, pp. 2866-2871

DOI: 10.1093/ndt/gfp181

Field-Weighted Citation Impact: 4.98

Command Palette

Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system

Authors

Abstract

Topics & Keywords

Publication Details